You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 7,964,357

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,964,357

Title:	Isolated genomic polynucleotide fragments from chromosome 12 that encode human mouse double minute 2 homolog
Abstract:	The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human carboxypeptidase M and human mouse double minute 2 homolog and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
Inventor(s):	Ryan; James W (Augusta, GA)
Assignee:	Ryogen LLC (Suffern, NY)
Application Number:	12/795,864
Patent Claims:	1. A method for isolating a nucleic acid molecule 20-51039 contiguous nucleotides in length consisting of a reverse or forward strand of a region of SEQ ID NO:4, wherein said region is selected from the group consisting of a 5'-non coding region between nucleotides 51039-41739 of SEQ ID NO:4; a 3'-non-coding region between nucleotides 9503-1 of SEQ ID NO:4; a contiguous intron-exon region between nucleotides 41738-9502 of SEQ ID NO:4, wherein a sequence segment between nucleotides 41738-9502 of SEQ ID NO:4 encodes human mouse double minute 2 homolog depicted in SEQ ID NO:2; a contiguous exon-intron region between nucleotides 41738-9502 of SEQ ID NO:4, wherein a sequence segment between nucleotides 41738-9502 of SEQ ID NO:4 encodes human mouse double minute 2 homolog depicted in SEQ ID NO:2; an intron depicted in nucleotides 36385-40645, 36309-33127, 32994-29616, 29564-25577, 25507-25384, 25287-21169, 21006-14110, 13953-13267, and/or 13188-10665; a region comprising a dinucleotide of the following group: 41739-41738, 40645-40646, 36309-36310, 36384-36385, 32994-32995, 33126-33127, 29564-29565, 29615-29616, 25507-25508, 25287-25288, 25383-25384, 25576-25577, 21006-21007, 21168-21169, 14109-14110, 13953-13954, 13266-13267, 13188-13189, 10664-10665 and/or 9504-9503; a transcription binding site selected from the group consisting of BINDING SITES huMDM2, location in SEQ ID NO:4 AP1_C: 36-46, 2876-2886; AP4_Q5: 7944-7980; AP4_Q6: 7943-59, 8924-8940, 9294-9310; ARNT.sub.--01: 1682-1706, 2193-2217, 9201-9225; BRN2.sub.--01: 1040-1058, 7803-7821; CAAT.sub.--01: 3292-3306; CDPCR3HD.sub.--01: 6522-6540; CEBPB.sub.--01: 1424-1438, 3917-3931, 4178-4192, 4787-4801, 6855-6869; CREL.sub.--01: 5630-5642; DELTAEF1.sub.--01: 83-95, 6328-6340; FREAC7.sub.--01: 2757-2773, 5154-5170, 5823-5839; GATA1.sub.--04: 4846-4858, 7017-7029; GATA1.sub.--05: 8464-8476; GATA2.sub.--02: 6045-6057, 6073-6085, 6142-6154; GATA2.sub.--03: 2489-2501, 3323-3335, 3384-3396, 7393-7405: GATA3.sub.--02: 3264-3276, 6870-6882: GATA3.sub.--03: 40-52, 5729-5741, 6529-6541, 6874-6886, 7041-7053, 7589-7601; GATA_C: 7 349-7361, 8188-8200; HFH2.sub.--01: 1743-1759, 7995-8011; HFH3.sub.--01: 502-518, 1739-1755, 4160-4176, 9402-9418, 9418-9434; HFH8.sub.--01: 8184-8200; IK2.sub.--01: 951-963, 3588-3600; MZF1.sub.--01: 1202-1210, 1447-1455, 4997-4005, 5424-5432; NF1_Q6: 1480-1500, 8166-8182; NFAT_Q6: 4190-4208, 6009-6027; NKX25.sub.--01: 741-755, 1648-1662, 1885-1899, 1984-1998, 3609-3623, 4928-4942, 5060-5074, 5889-5903, 8850-8864, 9190-9204; NKX25.sub.--02: 2584-2599, 2970-2984, 4644-4658, 5179-5193, 6482-6496; NMYC.sub.--01: 2560-2572; RORA101: 220-238, 2638-2656; S8.sub.--01: 4644-4656, 4842-4854, 4845-4857, 5200-5212, 5371-5383, 5735-5747, 6482-6494, 6541-6553, 6544-6556, 6772-6784, 7270-7292, 7273-7285; SOX5.sub.--01: 1355-1371, 1430-1446, 3094-3110, 3155-3171, 4669-4685, 4692-4708, 4789-4805; SRY.sub.--02: 4164-4180, 5665-5681; TATA.sub.--01: 1261-1277, 2574-2590, 2723-2739, 2733-2749, 2770-2786, 4199-4215, 4206-4222; TATA_C: 5900-5916, 7456-7472, 7702-7718, 7917-7933; and XFD2.sub.--01: 7702-7218, 7917-7933; a transcription binding site selected from the group consisting of BINDING SITES huMDM2, location in SEQ ID NO:4 ANS: 12109-12119, 12695-12705, 22600-22610, 24166-24176, 31311-31321, 35234-35244, 39184-39194; AP1_Q2: 11952-11962, 12068-12078, 14798-14808, 21748-21758, 22613-22623, 23676-23686, 26562-26572, 30046-30056; AP1_Q4: 12695-12705, 31311-31321, 35234-35244, 36295-36305, 38784-38794, 39188-39198; AP4_Q6: 31635-31651; BRN2.sub.--01: 13448-13466, 14764-14782, 28094-28112, 40027-40045; CAAT.sub.--01: 11288-11302, 15054-15068; CDPCR3HD.sub.--01: 11286-11304, 13284-13302, 20846-20864, 29344-29362; CEBPB.sub.--01: 29241-29255; CREL.sub.--01: 36091-36103, 38873-38885; DELTAEF1.sub.--01: 18083-18095, 20385-20397, 26955-26967; FREAC7.sub.--01: 11982-11998, 15187-15202, 16523-16539, 16529-16545, 16587-16603, 16604-16620, 16676-16642, 16633-16649, 16644-16660, 16650-16666, 16657-16673, 16673-16689, 16762-16778, 21332-21348, 25689-25700, 26529-26545, 27767-27783, 29495-29511; GATA1.sub.--02: 10916-10928, 15775-15789, 18162-18174, 26088-26100, 32518-32530; GATA1.sub.--03: 28012-28024; GATA1.sub.--04: 11153-11165, 11630-11642, 13778-13790, 17439-17451, 19300-19312, 21606-21618, 22743-22755, 23747-23759, 25806-25818, 26529-26541, 29424-29436, 30455-30467, 32761-32778, 33352-33364, 33960-33972, 36101-36113, 40007-40019; GATA1.sub.--05: 11590-11602, 26550-26562, 36737-36749; GATA1.sub.--06: 18772-18784, 23054-23066, 35568-35580, 37855-37867; GATA2.sub.--02: 20755-20767, 30830-30842, 34755-34767, 36285-36297, 39143-39155, 39641-39653, 40586-40598; GATA2.sub.--03: 13535-13547, 22711-22723, 23161-23173, 25028-25040, 27237-27249, 36277-36289; GATA3.sub.--02: 11558-11570, 16470-16482, 17225-17237, 19619-19631, 22156-22168, 22443-22455, 24713-24725, 27619-27631, 32716-32728, 34124-34136, 34163-34175, 36832-36844, 38403-38415; GATA3.sub.--03: 10869-10881, 11515-11527, 13845-13857, 17221-17233, 18952-18964, 20050-20062, 40171-40183; GATA_C: 15848-15860, 18899-18911, 23640-23652, 29072-29084, 30881-30893, 33198-33210, 37472-37484, 38621-38633; GFI1.sub.--01: 35469-35481, 35492-35504; HFH2.sub.--01: 15939-15955, 24636-24652, 25866-25882, 32171-32187, 35372-35388, 39457-35473; HFH3.sub.--01: 13340-13356, 19218-19234, 21328-21344, 21336-21352, 21344-21360, 28062-28078, 32125-32141; HFH8.sub.--01: 14133-14149, 22578-22584; HNF3B.sub.--01: 13150-13166, 16505-16521, 25264-25280, 29443-29459, 37654-37670; IK2.sub.--01: 11547-11559, 17144-17156, 18961-18973, 23883-23895, 27617-27629, 28908-28920, 29241-29253, 30752-30764, 34768-34780; LYF1.sub.--01: 12319-12331, 19191-19203, 37226-37238, 39430-39442; MAX.sub.--01: 22974-22986, 33339-33351; MZF1.sub.--01: 26105-26113, 35187-35195; NF1_Q6: 12048-12064, 33334-33354; NFAT_Q6: 13295-13313, 14157-14175, 14311-14329, 14414-14432, 18269-18287, 19326-19344, 20801-20819, 21177-21195, 22537-22555, 23861-23879, 25392-25410, 25879-25897, 27524-27542, 30636-30654, 30718-30736, 31525-31543, 33655-33673, 34726-34744, 34917-34535, 34990-35008, 35979-35997, 36479-36493, 36577-36595, 37154-37172, 40224-40242, 40365-40383; NKX25.sub.--01: 12041-12055, 12340-12354, 12471-12485, 12742-12756, 12877-12891, 13849-13863, 18995-19009, 21440-21454, 21883-21897, 28426-28440, 30964-30978, 32033-32047, 32265-32279; NKX25.sub.--02: 10998-11012, 12711-12725, 14131-14145, 14726-14740, 16024-16038; NMYC.sub.--01: 18753-18765, 18754-18766, 23076-23088, 30534-30546, 34400-34412; RORA101: 13134-13152, 22966-22984, 24934-24952, 33341-33359, 34760-34778; S8.sub.--01: 11000-11012, 11977-11989, 12048-12060, 12051-12063, 13747-13759, 13923-13935, 13926-13938, 14676-14688, 14679-14691, 16026-16038, 16313-16325, 16316-16328, 17515-17527, 20756-20768, 20759-20771, 23154-23166, 23157-23169, 25198-25210, 25201-25213, 26651-26663, 27508-27520, 27511-27523, 29450-29462, 29478-28490, 29775-29787, 29778-29790, 29813-29825, 29816-29828, 31329-31341, 31677-31689, 31680-31692, 31732-31744, 31735-31747, 36137-36149, 36140-36152, 36812-36824, 36815-36827, 37413-37425, 38679-38691, 39474-39486, 39477-39489; SOX5.sub.--01: 27397-27413, 27572-27588, 28100-28116, 29230-29246, 29439-29455, 30690-30706, 31595-31611, 33871-33887, 34113-34129, 34624-34640, 37668-37684, 38582-38598, 39124-39140, 40410-40426; SRY.sub.--02: 20016-20032, 22410-22426, 27329-27345, 29162-29178, 29499-29515, 30646-30662, 31503-31519, 35928-35944, 37324-37340; TATA.sub.--01: 32722-32738, 32729-32745, 32807-32823, 33825-33841, 34120-34136, 35433-35449, 36593-36609; TATA_C: 11015-11031, 11817-11833, 13635-13651, 14930-14946; TCF11.sub.--01: 18543-18549, 22574-22580, 31281-31297, 31489-31505, 38754-38770; USF.sub.--01: 23075-23087, 32577-32589; VMYB.sub.--02: 11526-11538, 17384-17396, 18400-18412, 19549-19561, 22188-22200, 40486-40508 and XFD2.sub.--01: 16620-16636, 18153-18169, 22102-22118, 23141-23157; And a transcription binding site selected from the group consisting of BINDING SITES huMDM2,1 location in SEQ ID NO:4 AP1_C: 44584-44594, 49069-49079: AP1_Q2: 42174-42184, 45217-45227, 48422-48422, 50447-50457; AP1_Q4: 42702-42712, 50806-50816; AP4_Q6: 42117-42133, 42118-42134, 42244-42260, 45432-45448; 45433-45449, 46609-46625; BRN2.sub.--01: 42310-42328, 44022-44040, 47514-47532, 48900-48918, 48967-48985; CAAT.sub.--01: 44866-44880; CDPCR3HD.sub.--01: 45671-45689, 49219-49237; CREL.sub.--01: 42437-42449, 49797-49809; FREAC701: 47026-47042, 47292-47308, 47658-47674; GATA1.sub.--02: 43482-43494, 48926-48938, 49284-49296; GATA1.sub.--03: 47371-47383; GATA1.sub.--04: 43054-43066, 43162-43162, 43967-43979, 45464-45476, 45916-45928, 47763-47775; GATA1.sub.--05: 49319-49331, 49459-49471; GATA1.sub.--06: 47590-47602; GATA2.sub.--02: 42660-42672, 43475-43487; GATA2.sub.--03: 43714-43726, 50948-50960; GATA3.sub.--02: 49155-49167, 49844-49856; GATA3.sub.--03: 42202-42214, 44810-44822, 48438-48450, 49136-49148, 49337-49349, 49869-49881; GATA_C: 44011-44023, 45256-45268, 45823-45835, 47915-47927, 49201-49213, 49573-49585; GFI1.sub.--01: 46606-46618, 47063-47075; HFH301: 47030-47046, 47284-47300, 47288-47304; IK2.sub.--01: 45275-45287; LYF1.sub.--01: 44564-44576, 46991-47003, 49567-49579; MAX.sub.--01: 43234-43246, 48726-48738; MZF1.sub.--01: 41772-41780, 42290-42298, 42295-42303, 44507-44515, 45105-45113, 45203-45211, 49948-49956, 50774-50782; NF1_Q6: 50209-50229; NFAT_Q6: 42061-42079, 44418-44436, 46399-46417, 47974-47992, 49267-49285, 49964-49982, 50392-50410; NKX25.sub.--01: 42394-42408, 43507-43521, 46115-46129; RORA1.sub.--01: 45073-45091, 48718-48736; S8.sub.--01: 43552-43564, 45214-45226, 47160-47172, 48419-48431, 49295-49307, 50379-50391; SOX5.sub.--01: 43716-43732, 46351-46367, 47156-47172, 47774-47790, 47868-47884, 47974-47990, 48915-48931, 50323-50339; TATA.sub.--01: 45588-45604, 47625-47641, 48026-48042, 48659-48675, 49056-49072, 49079-49095, 49152-49168; TCF11.sub.--01: 49115-49131; VMYB.sub.--02: 42010-42022, 42279-42291, 44651-44663; and XFD2.sub.--01: 42870-42886, 42910-42926 Comprising (a) isolating genomic DNA from a subject; (b) providing primers, probes and optionally polymerase and (c) incubating (a) and (b) under conditions promoting the isolation of said nucleic acid molecule.

Details for Patent 7,964,357

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986	⤷ Try a Trial	2023-06-27
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132		⤷ Try a Trial	2023-06-27
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132		⤷ Try a Trial	2023-06-27
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.